Soluble Transferrin Receptor in Athletes: sTfR as The Advanced Iron Marker
Table of Contents
Introduction: When Your Iron Test Doesn’t Tell the Whole Story
Interpreting iron status in athletic patients is often more complex than in the general population. Ferritin, in particular, behaves differently in physically active individuals, and the physiological effects of training can significantly complicate its interpretation. Recent heavy training can transiently complicate ferritin interpretation in athletes, because ferritin is an acute-phase reactant and may rise with inflammation even when iron availability is suboptimal [2][6].
The role of the Soluble Transferrin Receptor in athletes is particularly important in this context. It reflects cellular iron demand directly, rises specifically in response to iron deficiency and increased erythropoiesis, and is relatively unaffected by the inflammatory noise that confounds ferritin in athletes [2][3]. For sports medicine practitioners, coaches working with medical staff, and athletes navigating their own blood work, understanding sTfR is increasingly essential. In Finland, the test is commonly referred to simply as “TfR” in everyday clinical language, although in practice this corresponds to the soluble transferrin receptor (sTfR).
In my experience, sTfR is a practical test that is available in many clinical settings, including Finnish clinics. However, I do not typically use it as a first-line investigation. Instead, I consider it a more specialised marker and interpret it as part of a comprehensive iron panel. In my day-to-day clinical work, I order sTfR relatively infrequently. I tend to reserve it for more detailed anemia workups, and in many cases, it is not included in standard occupational health testing packages. That said, in athletic patients it can be particularly useful.
What Is the Soluble Transferrin Receptor in Athletes?
The transferrin receptor is a membrane glycoprotein expressed on virtually all cells that require iron. It captures circulating transferrin — the iron-transport protein — and draws iron into the cell. When cells are iron-starved, they upregulate transferrin receptor expression to increase uptake. A truncated fragment of this receptor is cleaved from the cell surface and enters the bloodstream, where it can be measured as the soluble transferrin receptor [3].
Structurally, sTfR is a truncated monomer of the tissue receptor, lacking its first 100 amino acids, and circulates as a complex with transferrin [3]. The primary source of circulating sTfR is erythroid precursor cells (erythroblasts) in the bone marrow, which have exceptionally high iron requirements for hemoglobin synthesis — though other cells also contribute in smaller amounts [3]. sTfR therefore reflects two things simultaneously: the degree of cellular iron deficiency across body tissues, and the overall rate of red blood cell production (erythropoiesis). This dual role explains why the Soluble Transferrin Receptor in athletes is particularly useful in identifying early functional iron deficiency.
The critical biological distinction from ferritin is this: ferritin is regulated by inflammatory cytokines — particularly interleukin-6 — which can elevate ferritin independently of actual iron stores, reducing its specificity for iron depletion. sTfR, by contrast, is regulated by cellular iron demand and erythropoietic activity, not inflammation [3][6]. sTfR is normal in the anemia of chronic inflammation but elevated in true iron deficiency, making it an important tool for distinguishing between the two [3].
In practice, ferritin can be influenced by recent training, particularly in the 24–72 hours following a heavy session. For some of my patients who train frequently, this can make ferritin values more difficult to interpret in isolation. For this reason, I rarely rely on ferritin alone, and instead consider it in the context of recent training load and alongside other iron markers.
Reference ranges vary considerably between assays because there is no international standardisation for sTfR measurement [3]. Many immunoassays report “normal” sTfR in the low single-digit mg/L range, but exact reference intervals depend entirely on the analytical platform used. In sports medicine practice, some studies use sTfR values above 4.13 mg/L — in combination with ferritin below 35 µg/L and transferrin saturation below 16% — to define the transition from pre-latent to latent iron deficiency in athletes; this is study-specific, not a universal guideline [2]. This assay variability is not a minor caveat: it is a major practical limitation, and athletes should use the same laboratory for longitudinal monitoring.
Why Ferritin Alone Falls Short in Athletes
A retrospective analysis of 629 competitive athletes found iron deficiency rates of 10.9% in males and 35.9% in females [2]. The classification required sTfR alongside ferritin — without the combined assessment, a substantial proportion of these athletes would have been misclassified. Athletes with inflammation-elevated ferritin might be falsely reassured; those with training-related dilution of ferritin might be unnecessarily alarmed.
A systematic review of 23 studies involving 669 female athletes across 16 sports confirmed that iron deficiency reduces endurance performance by approximately 3–4% in high-level female athletes with documented iron deficiency, with endurance performance improving by 2–20% following supplementation [7]. The wide range of the improvement figures reflects heterogeneous study designs and baseline deficiency levels across the reviewed literature — individual responses vary considerably. At competitive margins, however, even a 3% decrement is decisive.
Iron Deficiency Stages in Athletes: Where sTfR Fits
| Marker | Stage 1 (Pre-latent) | Stage 2 (Latent / IDNA) | Stage 3 (Anemia) |
| Ferritin | Low (<30–35 µg/L) | Low | Very Low |
| sTfR | Normal | Elevated (>4.1 mg/L*) | High |
| Hemoglobin | Normal | Normal | Low |
| Performance | Usually normal | ~3–4% decrement | Severe decline |
*Study-specific threshold (Roy et al. 2022 [2]); apply assay-specific reference ranges in clinical practice.
sTfR is most diagnostically valuable at Stage 2 — iron-deficient non-anemic (IDNA) status — where ferritin has become unreliable and anemia has not yet developed. This is the zone where detection and intervention matter most [2][4].
When both sTfR and ferritin are measured, the sTfR/log ferritin index (sometimes referred to as the Thomas Plot) provides the most comprehensive picture of iron availability across the full range of iron stores [3]. A study of 252 athletes using this index found latent iron deficiency in 26% of female athletes and 11% of male athletes, all non-anemic — athletes who would have been missed by hemoglobin testing alone [4]. In athlete studies, the sTfR/log ferritin index has improved detection of latent iron deficiency, but cut-offs are assay- and study-specific rather than universal [4].
The sTfR/log ferritin index uses the logarithm of ferritin rather than raw ferritin values because ferritin does not behave linearly across its range. Log transformation reduces the skew of ferritin values and provides a more stable and clinically meaningful relationship with sTfR, improving the assessment of functional iron availability
The sTfR/log ferritin index is, in principle, a practical and relatively simple parameter to use, as it requires only a single measurement of sTfR and ferritin. However, in everyday clinical practice, it remains relatively unfamiliar to many general clinicians and is more commonly used by hematologists and sports medicine specialists. In addition, the index is not fully standardised, is not routinely included in clinical guidelines, and is not part of standard hematological diagnostic protocols.
When to Add sTfR to the Athlete’s Blood Panel
sTfR should not replace ferritin in routine screening — it is a second-level marker that adds diagnostic precision in specific circumstances.
Elevated CRP or recent intense training. When ferritin cannot be ftrusted because inflammation is present, sTfR and particularly the sTfR/log ferritin index are preferable, being far less influenced by acute-phase responses than ferritin alone [6].
Ferritin in the grey zone. Ferritin between approximately 20–50 µg/L in athletes is particularly ambiguous. sTfR adds clarity: if ferritin is borderline and sTfR is normal, tissue iron supply is likely adequate; if sTfR is elevated alongside low-normal ferritin, functional deficiency is more probable [2].
Monitoring treatment response. A prospective clinical trial in elite non-anemic female athletes demonstrated that 60 days of supplementation with 105 mg elemental iron daily reduced sTfR from 3.46 to 3.16 mg/L (P=0.006), raised ferritin from 19.7 to 37.4 ng/mL, and reduced the sTfR/log ferritin index from 1.34 to 1.00 [1]. The index showed the most sensitive response to treatment.
In practice, resource limitations are often a key constraint. In many occupational health contracts, sTfR is not included, and many athletes — at least in Finland — operate on relatively limited budgets. As a result, ferritin — typically measured alongside a complete blood count — is often used as the first-line investigation when assessing iron status under financial constraints. Many athletes rely on grants or balance training with studies or work, which can limit access to more comprehensive testing.
Insurance coverage can further restrict investigations. In many cases, reimbursement requires a clear diagnosis of anemia, and optimizing athletic performance alone is rarely considered a sufficient medical indication.
Conclusion
Assessing iron status in athletes requires more than a single laboratory value. While ferritin remains the cornerstone of initial evaluation, its interpretation is often complicated by the physiological effects of training and inflammation. In this context, sTfR offers a valuable additional perspective by reflecting cellular iron demand and erythropoietic activity more directly.
In my clinical experience, sTfR is not a routine test, but in selected cases — particularly in athletic patients with borderline or unclear iron status — it can provide meaningful additional insight. When used alongside ferritin and other markers, it helps build a more complete picture of iron availability, especially in the early stages of deficiency where performance may already be affected but standard markers remain inconclusive.
At the same time, it is important to recognise the practical limitations. sTfR and the sTfR/log ferritin index are not fully standardised, are not included in most clinical guidelines, and may not be readily accessible in all settings due to cost or logistical constraints. For this reason, their use should be targeted rather than routine.
Ultimately, the goal is not to replace ferritin, but to interpret it more intelligently. In athletes — where physiology differs from the general population and small performance changes matter — combining clinical context with selected additional markers such as sTfR can improve diagnostic accuracy and support more informed decision-making.
References
- https://pubmed.ncbi.nlm.nih.gov/15377970/
- https://pmc.ncbi.nlm.nih.gov/articles/PMC9657900/
- https://pubmed.ncbi.nlm.nih.gov/12589962/
- https://pubmed.ncbi.nlm.nih.gov/11255135/
- https://pubmed.ncbi.nlm.nih.gov/15354029/
- https://pmc.ncbi.nlm.nih.gov/articles/PMC5878890/
- https://pubmed.ncbi.nlm.nih.gov/39536912/
